Malignancy Genomics and Immuno-Oncological Markers to Control Insusceptible Treatments
The Cancer Genomic Atlas (TCGA) is an openly available malignant growth information
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
The Cancer Genomic Atlas (TCGA) is an openly available malignant growth information
vitamin B12 could be a real marker in the diagnosis/prognosis of these diseases, and should not be neglected in geriatric oncology
carcinoma serum index (ratio of Orosomucoid and Prealbumin). For the study of inflammatory markers of oncological patients by MDA, following statistical software packages were used: Statgraphics Plus 5.1, Systat…
carcinoma serum index (ratio of Orosomucoid and Prealbumin). For the study of inflammatory markers of oncological patients by MDA, following statistical software packages were used: Statgraphics Plus 5.1, Systat…
Biochemical and molecular tumor markers are critical tools in the field of neuro-oncology, offering insights into the biological characteristics, prognosis, and treatment response ... brain tumors. This review explores…
vitamin B12 could be a real marker in the diagnosis/prognosis of these diseases, and should not be neglected in geriatric oncology
prostate specific antigen) is an oncological marker used for the diagnosis and prognosis of prostate cancer and other conditions such as BPH (benign prostatic hyperplasia) and prostatitis. It is produced
During the last decade, there has been increasing interest in the use
powerful antioxidant that suppresses lipid oxidation, have been viewed by clinicians as a marker of liver dysfunction. Epidemiological research has demonstrated an inverse relationship between elevated serum bilirubin…
On the basis of experimental data we suggest that discovered differences in
Cancer remains one of the leading causes of mortality worldwide, largely due
response to cancer, have emerged as pivotal tools in oncology for diagnosis, prognosis, treatment monitoring, and research. These markers, ranging from proteins and enzymes to genetic materials, hold immense promise…
three months, is hospitalized in our division. Risk factors: arterial hypertension. Performed oncological markers, EGDS and colonoscopy, autoimmunity, thyroid and dyslipidemia profile with negative results…
usually unfavorable.This study focuses on AFP, AFP L 3, and PIVKA II as oncological markers of HCC in patients with chronic viral hepatitis. It was found that
Single-walled carbon nanotube (SWCNT) field-effect transistors (FETs) were fabricated on
detection of prostate-specifi c-antigen (PSA) (Hassan et al., 2007) which is an oncological marker for the presence of prostate cancer. Herein CNT-based FETs were fabricated on strontium
The aim of this study is to evaluate FAS as a marker
Background: The carcinoembryonic antigen (CEA) is widely used as a tumor marker
Growing teratoma syndrome (GTS) is a rare disease occurring in patients with
For authors and organisers
Find the right journal for your paper and submit your manuscript.